Article

Smartphones Could Monitor Parkinson's Effect on Life

Author(s):

Researchers were able to pull 25,000 hours of monitoring data.

Sensor data from smartphones have been found to be capable of providing once inaccessible insides into the daily behavior and motor functioning of Parkinson’s disease (PD) patients, according to a study presented Tuesday, June 5 at the 21st International Congress of Parkinson’s Disease and Movement Disorders in Vancouver, BC.

The possibility of smartphone-based assessments and sensors that could enable remote, passive monitoring of gait and mobility in early stages of PD was investigated by a team of researchers based in Basel, Switzerland.

A clinical trial studied 44 PD patients carrying smart phones on their person for 24 weeks in a home-based setting. The phones, being carried in patients’ pockets or waist packs throughout the day, measured continuous movement and location.

Researchers then categorized data into different types of routine human activities, then compared to the study’s clinical data. Comparisons included the MDS Unified Parkinson’s Disease Rating Scale (MDS-UPDRS).

The trial managed to compile over 25,000 hours of passive monitoring data, and the measured mobility patterns correlated with disease severity, as measured by clinical gold standards.

Alberto Espay, associate professor of Neurology at the University of Cincinnati, said that if even the preliminary evidence only suggests that smartphones could be an untapped source of additional PD patient mobility data, the presented abstract is of interest.

“This is also important because of what is referred to as the ecologically valid setting in which the data are collected, outside of a clinic or movement laboratory.” Espay said.

Espay expressed caution for passive data collection, noting algorithms used for collection will need to be able to distinguish different types of movement — such as deliberate movement, peak-dose dyskinesia, or diphasic dyskinesia for movement disorder patients.

The algorithms will also have to distinguish different types of rest, from acts as simple as sitting and reading, to sleeping, Espay said.

Related Videos
Ben Samelson-Jones,Ben Samelson-Jones, MD, PhD: Validating Long-Term Safety of Hemophilia AAV Gene Therapy MD, PhD: Validating Long-Term Safety of Hemophilia AAV Gene Therapy
Françoise Bernaudin, MD: A Decade of Follow-up Reveals allo-SCT Superiority Over SOC for Sickle Cell Anemia
Achieving Quick Responses in Sickle Cell Anemia With Early, Appropriate Hydroxyurea Dosing, with Abena Appiah-Kubi, MD, MPH
Steven W. Pipe, MD: Fitusiran With Anti-Thrombin Modulation Yields Effective Bleed Control, Reduces Infusions
Caroline Piatek, MD: Improving Patient-Reported Outcomes in PNH With Danicopan Add-on Therapy
Haydar Frangoul, MD: Preventing VOCs in People With Sickle Cell Disease With Exa-Cel Gene Editing Therapy
Jörn Schattenberg, MD | Credit: Novo Nordisk
Jörn Schattenberg, MD | Credit: Novo Nordisk
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
© 2024 MJH Life Sciences

All rights reserved.